AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,877,653 | -28.9% | 256,289 | +123.3% | 0.34% | -78.9% |
| Q1 2019 | $5,452,003 | -35.1% | 114,779 | -50.7% | 1.59% | -65.1% |
| Q4 2018 | $8,403,719 | +13.1% | 232,790 | +92.8% | 4.55% | +39.6% |
| Q3 2018 | $7,429,762 | -51.5% | 120,711 | -46.8% | 3.26% | -53.5% |
| Q2 2018 | $15,327,230 | +34.0% | 226,902 | +7.6% | 7.01% | +32.0% |
| Q1 2018 | $11,434,707 | -20.7% | 210,778 | -12.7% | 5.31% | -36.0% |
| Q4 2017 | $14,428,430 | – | 241,480 | – | 8.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |